ZEN Graphene Solutions Ltd. and is pleased to announce that the University of Guelph has filed a provisional patent regarding an electrochemical exfoliation process to produce graphene oxide from Albany PureTM Graphite. Highlights: ZEN and Guelph file patent on novel GO production method Exfoliation method is designed to be scalable, low cost, low [...]
ZEN Graphene Solutions Ltd. is pleased to report that after 5 months of optimization, it has developed a novel graphene-based virucidal ink with 99% effectiveness against COVID-19. Highlights: ZEN's Virucidal ink is 99% effective against the COVID-19 virus ZEN's Virucidal ink was still 99% effective a minimum of 35 days after application to N95 [...]
ZEN Graphene Solutions Ltd. Shareholders are welcome to attend the Company's annual meeting of shareholders on September 28, 2020. Due to COVID-19 and its threats to the community we are required to follow new procedures at our upcoming annual meeting of shareholders. Those procedures are described below and were designed within the requirements [...]
ZEN Graphene Solutions Ltd. is pleased to report that industry and university laboratories fully re-opened in late July-early August after a 4 month hiatus due to the Covid-19 pandemic and they have re-started ZEN's collaborative R&D programs. ZEN will report shortly on significant progress being made in multiple programs, one of which has resulted [...]
ZEN Graphene Solutions Ltd. is pleased to announce that a recent peer reviewed research article clearly demonstrates that ZEN's Albany Graphite exfoliates more easily than other commercially available flake graphite test samples. Significantly, this article provides quantitative data that ZEN's Albany PureTM Graphite has the highest exfoliation [...]
ZEN Graphene Solutions Ltd. is pleased to announce it has commenced collaborations with research teams at a number of personal protective equipment manufacturers to incorporate ZEN's virucidal graphene ink into commercial products, including masks, gloves, gowns and other clothing following Zen's promising results for an antiviral, graphene-based [...]
ZEN Graphene Solutions Ltd. is pleased to announce that it has retained Hybrid Financial Ltd. to provide marketing services. Hybrid has been engaged to heighten market and brand awareness for ZEN Graphene Solutions and to broaden the Company's reach within the investment community. Francis Dubé, CEO commented, "As ZEN evolves from an exploration [...]
ZEN Graphene Solutions Ltd. is pleased to announce that Evercloak Inc. and ZEN have been awarded $125,000 each as part of a Next Generation Manufacturing Canada Project. The project entitled "Advancing Large-Scale Graphene and Thin-Film Membrane Manufacturing" will support the scale up of graphene oxide production by ZEN to supply GO to Evercloak [...]
ZEN Graphene Solutions Ltd. is pleased to announce the closing of the second tranche, comprised of 1,621,175 units, of its previously announced private placement of units . The Company raised total gross proceeds of $2,049,999.80 under the Offering, which will be used to fund ongoing work on the Albany Graphite Project including graphene research [...]
ZEN Graphene Solutions Ltd. is pleased to announce the closing of the first tranche of its previously announced private placement of units . The Company raised gross proceeds of $1,077,294.80 under the Offering, which will be used to fund ongoing work on the Albany Graphite Project including graphene research and scale up, COVID-19 initiatives and [...]
ZEN Graphene Solutions Ltd. is pleased to announce it has received expression of interest from investors in an amount of $1,777,000 for the non-brokered private placement announced on June 15, 2020. These expressions of interest have far exceeded management's expectation and, subject to TSX Venture Exchange approval, the Company is working [...]
ZEN Graphene Solutions Ltd. announces an offering of units of the Company on a non-brokered private placement basis. Each Unit is offered at a price of $0.60. The Offering is subject to TSX Venture Exchange approval. Each Unit will be comprised of one Common Share of the Company and one-half of one non-transferable Common Share purchase warrant [...]
